Fundraising Fox
/Companies
Sign in

Keyron

Founded 2016 · 8 employees on LinkedIn · 1 known investors

Find your way into Keyron

Each arrow is one introduction. Sign up to fill in the first one.

356 people can intro you to Giorgio

Ask Luca Melindo to introduce you to Giorgio Castagneto Gissey

You →Luca · together at Keyron →Giorgio

Sign up to find every way you can get introduced to Keyron

  • Your email: who you already know at Keyron, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Keyron team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Keyron develops ForePass, a fully endoscopic, non-invasive and reversible gastric bypass medical device intended to reproduce the effects of metabolic surgery for patients with Class II & III obesity, type 2 diabetes, MASH/NASH, and liver fibrosis. The company targets severe "diabesity" patients who refuse surgery or do not achieve results with drugs, across the US and EU5 markets.

BiotechHardwareMedical Devices

Founders & leadership

Keyron was founded in 2016 by Giorgio Castagneto Gissey.

GCGiorgio Castagneto Gissey
Giorgio Castagneto GisseyChief Executive, Chairman & Co-FounderDr Giorgio Castagneto Gissey is CEO and co-founder of Keyron, which develops an endoscopic gastric bypass device. He previously founded Metadeq, which developed a diagnostic for liver fibrosis, and GHP Scientific and Jemyll; he also held research and teaching positions at Imperial College and UCL, and holds a Ph.D. in Financial Economics from Imperial College Business School and an M.Sc. in Economics from the University of Warwick.
JPJoyce Peetermans
Joyce PeetermansActing CTO
DFDavid Feigal
David FeigalHead of Regulatory Affairs & Board Member
FRFrancesco Rubino
Francesco RubinoChief Officer for Obesity and Diabetes & Board Member
CLCarel le Roux
Carel le RouxChief Medical Officer & Director of Pharmaceutical Division
NV
Nicol VerheemChief Investment Officer, Director of Diagnostics Division & Board Member
MCMarco Castagneto
Marco CastagnetoChief Scientific Officer & Director of Medical Device Division

Board

GM
Geltrude MingroneChief Advisor

Investors · 1

Related companies · 1

Kairon HealthKairon Health offers a data platform for value-based care that ingests claims, clinical records, and qualitative data to run healthcare workflows including field team prep, care management, HCC coding, quality gap closure, and patient outreach. It serves provider organizations and their practices with tools for practice enablement, care operations, AI-driven patient activation, and impact analytics tied to billed visits.

Companies working in the same space as Keyron.

In the news

Keyron appoints new Chief Executive Officer - BioSpacebiospace.com · Feb 2023Investors - Keyronkeyron.com · Mar 2022

Frequently asked questions

What does Keyron do?
Keyron develops ForePass, a fully endoscopic, non-invasive and reversible gastric bypass medical device intended to reproduce the effects of metabolic surgery for patients with Class II & III obesity, type 2 diabetes, MASH/NASH, and liver fibrosis. The company targets severe "diabesity" patients who refuse surgery or do not achieve results with drugs, across the US and EU5 markets.
Who founded Keyron?
Keyron was founded by Giorgio Castagneto Gissey in 2016.
Who are Keyron's investors?
Keyron's investors include Health Wildcatters.